Compass Wealth Management LLC Buys New Shares in National Health Investors, Inc. (NYSE:NHI)

Compass Wealth Management LLC bought a new stake in National Health Investors, Inc. (NYSE:NHI) in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund bought 475 shares of the real estate investment trust’s stock, valued at approximately $30,000.

A number of other institutional investors have also recently bought and sold shares of the stock. Pensionfund DSM Netherlands grew its stake in National Health Investors by 5.6% during the first quarter. Pensionfund DSM Netherlands now owns 37,600 shares of the real estate investment trust’s stock worth $2,362,000 after buying an additional 2,000 shares during the period. PNC Financial Services Group Inc. boosted its stake in shares of National Health Investors by 6.4% in the fourth quarter. PNC Financial Services Group Inc. now owns 3,979 shares of the real estate investment trust’s stock valued at $222,000 after purchasing an additional 238 shares during the period. Land & Buildings Investment Management LLC boosted its stake in shares of National Health Investors by 81.8% in the fourth quarter. Land & Buildings Investment Management LLC now owns 412,052 shares of the real estate investment trust’s stock valued at $23,013,000 after purchasing an additional 185,377 shares during the period. Waterfront Capital Partners LLC purchased a new position in shares of National Health Investors in the fourth quarter valued at $21,863,000. Finally, Hsbc Holdings PLC boosted its stake in shares of National Health Investors by 14.7% in the fourth quarter. Hsbc Holdings PLC now owns 22,857 shares of the real estate investment trust’s stock valued at $1,277,000 after purchasing an additional 2,936 shares during the period. 62.51% of the stock is currently owned by hedge funds and other institutional investors.

Insider Transactions at National Health Investors

In related news, Director Robert A. Mccabe, Jr. purchased 437 shares of the stock in a transaction on Friday, May 31st. The shares were bought at an average price of $65.83 per share, for a total transaction of $28,767.71. Following the completion of the acquisition, the director now directly owns 21,585 shares in the company, valued at approximately $1,420,940.55. The purchase was disclosed in a document filed with the SEC, which can be accessed through the SEC website. 7.26% of the stock is owned by insiders.

National Health Investors Price Performance

NHI stock opened at $67.60 on Thursday. The firm has a 50-day moving average of $64.43 and a two-hundred day moving average of $59.43. The company has a current ratio of 13.24, a quick ratio of 13.24 and a debt-to-equity ratio of 0.91. The firm has a market capitalization of $2.94 billion, a PE ratio of 22.16 and a beta of 1.00. National Health Investors, Inc. has a one year low of $48.51 and a one year high of $68.14.

National Health Investors Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, August 2nd. Stockholders of record on Friday, June 28th will be given a $0.90 dividend. This represents a $3.60 dividend on an annualized basis and a dividend yield of 5.33%. The ex-dividend date of this dividend is Friday, June 28th. National Health Investors’s dividend payout ratio (DPR) is 118.03%.

Wall Street Analysts Forecast Growth

NHI has been the topic of a number of research reports. StockNews.com cut shares of National Health Investors from a “buy” rating to a “hold” rating in a report on Thursday, April 18th. Wedbush increased their target price on shares of National Health Investors from $64.00 to $66.00 and gave the company an “outperform” rating in a research report on Monday, March 18th. Truist Financial increased their target price on shares of National Health Investors from $55.00 to $58.00 and gave the company a “hold” rating in a research report on Thursday, April 4th. BMO Capital Markets upgraded shares of National Health Investors from a “market perform” rating to an “outperform” rating and set a $67.00 price objective for the company in a research report on Tuesday, March 12th. Finally, Wells Fargo & Company raised their price objective on shares of National Health Investors from $63.00 to $69.00 and gave the company an “overweight” rating in a research report on Thursday, May 30th. Five investment analysts have rated the stock with a hold rating and four have given a buy rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus target price of $61.25.

National Health Investors Company Profile

Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.